匹配配对比较:加速康复路径对肺手术患者阿片暴露与疼痛控制的影响
该研究在肺切除患者中比较ERAS路径与常规管理,采用倾向性1:1匹配,ERAS组123例,常规组907例中匹配。结果显示ERAS组住院阿片消耗显著降低,疼痛评分更低,但出院阿片处方比例因分析是否纳入曲马多而异。
要点
- ERAS路径显著降低肺切除患者住院阿片消耗。
- ERAS组平均每日疼痛评分更低,但差异仅见于开胸患者。
- 出院阿片处方比例取决于是否将曲马多计入阿片。
核心结论
- 实施ERAS路径与有效术后镇痛、住院阿片消耗大幅降低及疼痛减轻相关。
研究设计与样本
- 研究为匹配配对比较,ERAS组123例连续肺切除患者,与ERAS前907例连续患者按倾向性1:1匹配。
主要发现
- ERAS组硬膜外镇痛使用率为0%,对照组为66%(P < 0.001)。
- ERAS组术后辅助镇痛药数量中位数3种,对照组2种(P < 0.001)。
- 纳入曲马多时,ERAS组吗啡毫克当量中位数14.2 vs 57.8(P < 0.001);排除曲马多时2.7 vs 57.8(P < 0.001)。
- ERAS组平均每日疼痛评分中位数1.3 vs 1.8(P = 0.004),差异仅见于开胸患者。
- 出院阿片处方比例:纳入曲马多时两组均为96%(P = 1.00);排除曲马多时ERAS组39% vs 对照组80%(P < 0.001)。
临床怎么用
- 肺切除患者可考虑实施ERAS路径以减少住院阿片消耗并改善镇痛。
- 出院阿片处方需关注曲马多是否计入阿片分析,以准确评估处方率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to assess the effect of an enhanced recovery after surgery (ERAS) pathway on pain and opioid use following lung resection. SUMMARY BACKGROUND DATA: A major component ERAS pathways is opioid-sparing analgesia; however, the effect on postoperative pain and opioid use in patients undergoing lung resection is unknown. METHODS: Following implementation of an ERAS pathway for lung resection, 123 consecutive patients were identified. Patients were propensity-matched 1:1 with a group of consecutive patients (n = 907) undergoing lung resection before ERAS. Differences regarding in-hospital opioid consumption, discharge prescribing of opioids, and postoperative pain scores were examined. Morphine milligram equivalents were separately calculated including and excluding tramadol as an opioid medication. RESULTS: There were no significant differences between matched patients regarding age, sex, performance status, receipt of preoperative treatment, extent of lung resection, or operative approach. Epidural analgesia was used in 66% of controls and in none of the ERAS group (P < 0.001). The number of adjunct analgesics used postoperatively was greater in the ERAS group (median 3 vs 2, P < 0.001). There was a major reduction in morphine milligram equivalents in the ERAS group whether tramadol was included (median 14.2 vs 57.8, P < 0.001) or excluded (median 2.7 vs 57.8, P < 0.001) and regardless of surgical approach. Average daily pain scores were lower in the ERAS group (median 1.3 vs 1.8, P = 0.004); however, this difference was present only among patients undergoing thoracotomy. The proportion of patients who were prescribed discharge opioids varied whether tramadol was included (96% each group, P = 1.00) or excluded (39% vs 80%, P < 0.001) in the analysis. CONCLUSIONS: Implementation of an ERAS pathway was associated with effective post-operative analgesia, major reductions in in-hospital consumption of opioids, and reduced pain, compared to conventional management.
引用
- Rice D, Rodriguez-Restrepo A, Mena G, et al. Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery. Ann Surg. 2021. PMID: 32229762. doi:10.1097/SLA.0000000000003587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。